Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• (untitled)3 passages
• 2019 Chinese Clinical Practice Guidelines for the Prevention of Mother-to-child Transmission of Hepatitis B Virus.1 passage
• 3-year Treatment of Tenofovir Alafenamide1 passage
• A 3D Human Liver Model of Nonalcoholic Steatohepatitis.1 passage
• A Case Report of Alloimmune Hepatitis after Direct-acting Antiviral Treatment in a Liver Transplant Patient.1 passage
• A Deep Look into the Program of Rapid Tumor Growth of Hepatocellular Carcinoma.1 passage
• A Meta-analysis of the Value of vWF in the Diagnosis of Liver Cirrhosis with Portal Hypertension.1 passage
• A Mimic of Hepatic Encephalopathy: Two Cases of Cryptococcal Meningitis in North America.1 passage
• A Potential Functional Cure in Chinese HBeAg-negative Chronic Hepatitis B Patients Treated with Peg-interferon Alpha-2a.1 passage
• A Real-world Prospective Study of Mother-to-child Transmission of HBV in China Using a Mobile Health Application (Shield 01).1 passage
• A Review of Hepatitis B Virus and Hepatitis C Virus Immunopathogenesis.1 passage
• A Review of Non-operative Treatments for Hepatocellular Carcinoma with Advanced Portal Vein Tumor Thrombus.1 passage
• A Review on the Management of Biliary Complications after Orthotopic Liver Transplantation.1 passage
• A Simple and Quick Screening Method for Intrapulmonary Vascular Dilation in Cirrhotic Patients Based on Machine Learning.1 passage
• A Systematic Literature Review of Syphilitic Hepatitis in Adults.1 passage
• Accessibility to Oral Antiviral Therapy for Patients with Chronic Hepatitis C in the United States.1 passage
• Acetaminophen-Induced Hepatotoxicity: a Comprehensive Update.1 passage
• Acute Hepatic Phenotype of Wilson Disease: Clinical Features of Acute Episodes and Chronic Lesions Remaining in Survivors.1 passage
• Acute Hepatic Porphyria.1 passage
• Acute Kidney Injury at Admission Is a Better Predictor of Mortality than Its Persistence at 48 h in Patients with Acute-on-chronic Liver Failure.1 passage
• Acute Kidney Injury in Patients with Cirrhosis.1 passage
• Acute-on-chronic Liver Failure in a Patient with1 passage
• Alanine Aminotransferase as the First Test Parameter for Wilson's Disease.1 passage
• Alcohol and Metabolic-associated Fatty Liver Disease.1 passage
• Alcoholic Hepatitis: Lost in Translation.1 passage
• Alcoholic Liver Disease and COVID-19 Pneumonia: A Case Series.1 passage
• Aliphatic Halogenated Hydrocarbons: Report and Analysis of Liver Injury in 60 Patients.1 passage
• Alpha-1 Anti-trypsin Exerts a Hepatoprotective Effect on Immune-mediated Hepatitis and Acetaminophen-induced Liver Injury.1 passage
• An Ecological Evaluation of Vinyl Chloride Exposure and Liver Cancer Incidence and Mortality in Texas.1 passage
• An Update on Efficacy and Safety of Emerging Hepatic Antifibrotic Agents.1 passage
• Analysis of Clinicopathological Characteristics and Prognosis of Young Patients with Hepatocellular Carcinoma after Hepatectomy.1 passage
• Antihepatic Fibrosis Drugs in Clinical Trials.1 passage
• Approaches to Assessing Burden in Caregivers of Patients with Cirrhosis.1 passage
• Assessing the Effectiveness of Strategies in US Birth Cohort Screening for Hepatitis C Infection.1 passage
• Assessment of the Visual Analogue Score in the Evaluation of the Pruritus of Cholestasis.1 passage
• Association between NAFLD and Risk of Colorectal Adenoma in Chinese Han Population.1 passage
• Association of GCKR Gene Polymorphisms with the Risk of Nonalcoholic Fatty Liver Disease and Coronary Artery Disease in a Chinese Northern Han Population.1 passage
• Association of LDLR rs1433099 with the Risk of NAFLD and CVD in Chinese Han Population.1 passage
• Association of Overt Diabetes Mellitus with the Non-CC but not the CC Genotype of Interleukin-28B in Hepatitis C Virus Infected Patients.1 passage
• Association of TCF7L2 rs7903146 Gene Polymorphism with the Risk of NAFLD and CAD in the Chinese Han Population.1 passage
• Associations of Hydroxysteroid 17-beta Dehydrogenase 13 Variants with Liver Histology in Chinese Patients with Metabolic-associated Fatty Liver Disease.1 passage
• Asymptomatic Hepadnaviral Persistence and Its Consequences in the Woodchuck Model of Occult Hepatitis B Virus Infection.1 passage
• Autoimmune Hepatitis in the Asia-Pacific Area.1 passage
• Autotaxin: An Early Warning Biomarker for Acute-on-chronic Liver Failure.1 passage
• B Cell-mediated Humoral Immunity in Chronic Hepatitis B Infection.1 passage
• Bacterial Infections in Cirrhotic Patients in a Tertiary Care Hospital.1 passage
• Baseline Characteristics and Treatment Patterns of the Patients Recruited to the China Registry of Hepatitis B.1 passage
• Bile Cast Nephropathy in Patients with Acute Kidney Injury Due to Hepatorenal Syndrome: A Postmortem Kidney Biopsy Study.1 passage
• Biliary Mucinous Cystadenoma: A Review of the Literature.1 passage
• CA-125 Significance in Cirrhosis and Correlation with Disease Severity and Portal Hypertension: A Retrospective Study.1 passage
• COVID-19 and Indirect Liver Injury: A Narrative Synthesis of the Evidence.1 passage
• COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies.1 passage
• COVID-19 in Liver Transplant Recipients - A Series with Successful Recovery.1 passage
• COVID-19 in Liver Transplant Recipients.1 passage
• CT-MRI LI-RADS v2017: A Comprehensive Guide for Beginners.1 passage
• Candidate Biomarkers of Liver Fibrosis: A Concise, Pathophysiology-oriented Review.1 passage
• Cardiovascular Involvement in Chronic Hepatitis C Virus Infections - Insight from Novel Antiviral Therapies.1 passage
• Case Control Study of Post-endoscopic Variceal Ligation Bleeding Ulcers in Severe Liver Disease: Outcomes and Management.1 passage
• Celiac Disease and Elevated Liver Enzymes: A Review.1 passage
• Changing Population of Liver Transplant Recipients in the Era of Direct-acting Antiviral Therapy.1 passage
• Characteristics and Inpatient Outcomes of Primary Biliary Cholangitis and Autoimmune Hepatitis Overlap Syndrome.1 passage
• Characteristics and Mechanism of Liver Injury in 2019 Coronavirus Disease.1 passage
• Characteristics and Outcome of Exertional Heatstroke Patients Complicated by Acute Hepatic Injury: A Cohort Study.1 passage
• Characteristics and Outcomes of Acetaminophen Overdose and Hepatotoxicity in Thailand.1 passage
• Checkpoint Inhibition in the Treatment of Unresectable, Advanced Lymphoepithelioma-like Hepatocellular Carcinoma.1 passage
• Chemotherapy for Hepatocellular Carcinoma: Current Evidence and Future Perspectives.1 passage
• Cholangitis: Diagnosis, Treatment and Prognosis.1 passage
• Chronic Active Hepatitis B with COVID-19 in Pregnancy: A Case Report.1 passage
• Chronic Cholestatic Liver Injury Attributable to Vedolizumab.1 passage
• Chronic Hepatitis C Infection in Children: Current Treatment and New Therapies.1 passage
• Chronic Liver Disease and Silymarin: A Biochemical and Clinical Review.1 passage
• Chylous Ascites: A Review of Pathogenesis, Diagnosis and Treatment.1 passage
• Clinical Application of Vibration Controlled Transient Elastography in Patients with Chronic Hepatitis B.1 passage
• Clinical Course and Outcome Patterns of Acute-on-chronic Liver Failure: A Multicenter Retrospective Cohort Study.1 passage
• Clinical Factors Associated with Hepatocellular Iron Deposition in End-stage Liver Disease.1 passage
• Clinical Food Addiction Is Not Associated with Development of Metabolic Complications in Liver Transplant Recipients.1 passage
• Clinical Outcome Event Adjudication in a 10-Year Prospective Study of Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B.1 passage
• Clinical Updates in Primary Biliary Cholangitis: Trends, Epidemiology, Diagnostics, and New Therapeutic Approaches.1 passage
• Clinical Validation of Global Coagulation Tests to Guide Blood Component Transfusions in Cirrhosis and ACLF.1 passage
• Comparing the Efficacy and Safety of Treating Chronic Hepatitis B Infection during Pregnancy with Lamivudine, Telbivudine, and Tenofovir: A Meta-analysis.1 passage
• Comparison of Vitamin D Levels in Naive, Treated, and Inactive Carriers with Chronic Hepatitis B Virus.1 passage
• Complementary and Alternative Medicine-related Drug-induced Liver Injury in Asia.1 passage
• Copper Accumulates in Hemosiderins in Livers of Patients with Iron Overload Syndromes.1 passage
• Coronavirus Disease 2019 and Liver Injury: A Retrospective Analysis of Hospitalized Patients in New York City.1 passage
• Coronavirus Disease-2019 (COVID-19) and the Liver.1 passage
• Critically Ill COVID-19 Patient with Chronic Liver Disease - Insights into a Comprehensive Liver Intensive Care.1 passage
• Curing Hepatitis C in Liver Transplant Recipients Is Associated with Changes in Immunosuppressant Use.1 passage
• Current Knowledge on Hepatitis E.1 passage
• Current Management of Alcoholic Hepatitis and Future Therapies.1 passage
• Current Modalities of Fibrosis Assessment in Non-alcoholic Fatty Liver Disease.1 passage
• Current Scenario of Hepatitis B and Its Treatment in India.1 passage
• Current and Future Treatment of Hepatocellular Carcinoma: An Updated Comprehensive Review.1 passage
• Current and New Drugs for COVID-19 Treatment and Its Effects on the Liver.1 passage
• Cytokine Storm of COVID-19 and Its Impact on Patients with and without Chronic Liver Disease.1 passage
• Cytomegalovirus Hepatitis in Immunocompetent and Immunocompromised Hosts.1 passage
• De novo Hepatocellular Carcinoma after Liver Transplantation.1 passage
• Decrease of Alpha-fetoprotein in Patients with Cirrhosis Treated with Direct-acting Antivirals.1 passage
• Dermatologic Extrahepatic Manifestations of Hepatitis C.1 passage
• Detection of Hepatitis B Virus M204V Mutation Quantitatively via Real-time PCR.1 passage
• Development and Validation of a Metabolic-related Prognostic Model for Hepatocellular Carcinoma.1 passage
• Development and Validation of a Nomogram Based on Perioperative Factors to Predict Post-hepatectomy Liver Failure.1 passage
• Development and Validation of a Prognostic Model for One-year Survival of Cirrhosis Patients with First-ever Spontaneous Bacterial Peritonitis.1 passage
• Development and Validation of an RNA Binding Protein-associated Prognostic Model for Hepatocellular Carcinoma.1 passage
• Development of a Novel Endovascular Brachytherapy Stent: A Proof-of-concept Study.1 passage
• Diabetes Mellitus Predicts Occurrence of Cirrhosis and Hepatocellular Cancer in Alcoholic Liver and Non-alcoholic Fatty Liver Diseases.1 passage
• Diagnosis and Management of Alcoholic Liver Disease.1 passage
• Diagnostic and Therapeutic Strategies for Peritoneal Tuberculosis: A Review.1 passage
• Differentiating Cystic Liver Lesions: A Review of Imaging Modalities, Diagnosis and Management.1 passage
• Differentiation of Hepatocellular Carcinoma from Hepatic Hemangioma and Focal Nodular Hyperplasia using Computed Tomographic Spectral Imaging.1 passage
• Diminishing Use of Liver Biopsy among Liver Transplant Recipients for Hepatitis C.1 passage
• Direct-acting Antiviral Regimens for Patients with Chronic Infection of Hepatitis C Virus Genotype 3 in China.1 passage
• Direct-acting Antivirals and Host-targeting Agents against the Hepatitis A Virus.1 passage
• Diversity in NAFLD: A Review of Manifestations of Nonalcoholic Fatty Liver Disease in Different Ethnicities Globally.1 passage
• Drug Induced Liver Injury: Review with a Focus on Genetic Factors, Tissue Diagnosis, and Treatment Options.1 passage
• Drug-induced Fatty Liver Disease: Pathogenesis and Treatment.1 passage
• Drugs for Non-alcoholic Steatohepatitis (NASH): Quest for the Holy Grail.1 passage
• EUS-guided Gall Bladder Drainage in Severe Liver Disease: A Single-center Experience in Critically Ill Cirrhotics.1 passage
• Effect of Autologous Bone Marrow Stem Cell Therapy in Patients with Liver Cirrhosis: A Meta-analysis.1 passage
• Effect of Exercise on NAFLD and Its Risk Factors: Comparison of Moderate versus Low Intensity Exercise.1 passage
• Effect of Genistein in Comparison with Trichostatin A on Reactivation of DNMTs Genes in Hepatocellular Carcinoma.1 passage
• Effect of Hepatitis C Treatment on Renal Function in Liver Transplant Patients.1 passage
• Effect of Treatment for CHC on Liver Disease Progression and Hepatocellular Carcinoma Development in African Americans.1 passage
• Effectiveness of Ledipasvir/Sofosbuvir with/without Ribavarin in Liver Transplant Recipients with Hepatitis C.1 passage
• Effects of Bivalirudin and Unfractionated Heparin on Liver and Renal Function in Chinese Patients with Coronary Artery Disease Undergoing Coronary Angiography with/without Percutaneous Coronary Intervention.1 passage
• Effects of Granulocyte Colony-Stimulating Factor on Patients with Liver Failure: a Meta-Analysis.1 passage
• Efficacy and Safety of 12-week Interferon-based Danoprevir Regimen in Patients with Genotype 1 Chronic Hepatitis C.1 passage
• Efficacy and Safety of All-oral Emitasvir and Sofosbuvir in Patients with Genotype 1b HCV Infections without Cirrhosis.1 passage
• Efficacy and Safety of All-oral, 12-week Ravidasvir Plus Ritonavir-boosted Danoprevir and Ribavirin in Treatment-naïve Noncirrhotic HCV Genotype 1 Patients: Results from a Phase 2/3 Clinical Trial in China.1 passage
• Efficacy and Safety of Daclatasvir in Hepatitis C: An Overview.1 passage
• Efficacy and Safety of Direct-acting Antivirals in Hepatitis C Virus-infected Patients Taking Proton Pump Inhibitors.1 passage
• Efficacy and Safety of Glecaprevir/Pibrentasvir for Chronic Hepatitis C Patients: A Systematic Review and Meta-analysis.1 passage
• Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients with Chronic HCV Infection.1 passage
• Efficacy of Intragastric Balloons in the Markers of Metabolic Dysfunction-associated Fatty Liver Disease: Results from Meta-analyses.1 passage
• Elastography for Longitudinal Assessment of Liver Fibrosis after Antiviral Therapy: A Review.1 passage
• Elevated Liver Enzymes in Asymptomatic Patients - What Should I Do?1 passage
• Elimination of Hepatitis C in Liver Transplant Recipients.1 passage
• Emerging Trends in Epidemiology of Hepatitis B Virus Infection.1 passage
• Employment and Patient Satisfaction after Liver Transplantation.1 passage
• Epidemiology of Hepatitis E in Pregnant Women and Children in Iran: A General Overview.1 passage
• Evaluation of Biomarkers in Egyptian Patients with Different Grades of Nonalcoholic Fatty Liver Disease.1 passage
• Expanding Treatment Access for Chronic Hepatitis C with Task-shifting in the Era of Direct-acting Antivirals.1 passage
• Fatty Liver Disease and Gut Microbiota: A Comprehensive Update.1 passage
• FibroScan Detection of Fatty Liver/Liver Fibrosis in 2266 Cases of Chronic Hepatitis B.1 passage
• Future Pharmacotherapy for Non-alcoholic Steatohepatitis (NASH): Review of Phase 2 and 3 Trials.1 passage
• Greater Biosynthetic Liver Dysfunction in Primary Sclerosing Cholangitis Suggests Co-existent or Impending Cholangiocarcinoma.1 passage
• Guidelines for Prevention and Treatment of Chronic Hepatitis B.1 passage
• Gut Microbiome-based Therapeutics in Liver Cirrhosis: Basic Consideration for the Next Step.1 passage
• Gut Microbiota in Metabolic-associated Fatty Liver Disease and in Other Chronic Metabolic Diseases.1 passage
• HBV Integration Induces Complex Interactions between Host and Viral Genomic Functions at the Insertion Site.1 passage
• HBV cccDNA and Its Potential as a Therapeutic Target.1 passage
• HBV-HCV Coinfection: Viral Interactions, Management, and Viral Reactivation.1 passage
• HBsAg Loss with Peg-interferon Alfa-2a in Hepatitis B Patients with Partial Response to Nucleos(t)ide Analog: New Switch Study.1 passage
• HCV Extrahepatic Manifestations.1 passage
• HCV Therapy Follow-up Fractionation (CTF2) by Intra-PBMC Nested RNA PCR Recognizes Early Virologic Response and Relapse.1 passage
• HEV and HBV Dual Infection: A Review.1 passage
• HIV/HCV Antiviral Drug Interactions in the Era of Direct-acting Antivirals.1 passage
• Healthy Donor Fecal Microbiota Transplantation for Recurrent Bacterial Cholangitis in Primary Sclerosing Cholangitis - A Single Case Report.1 passage
• Hepatic Antifibrotic Pharmacotherapy: Are We Approaching Success?1 passage
• Hepatic Echinococcal Cysts: A Review.1 passage
• Hepatic Encephalopathy: An Update on the Pathophysiology and Therapeutic Options.1 passage
• Hepatic Resection Versus Stereotactic Body Radiation Therapy Plus Transhepatic Arterial Chemoembolization for Large Hepatocellular Carcinoma: A Propensity Score Analysis.1 passage
• Hepatitis B Management in the Pregnant Patient: An Update.1 passage
• Hepatitis B Reactivation with Novel Agents in Non-Hodgkin's Lymphoma and Prevention Strategies.1 passage
• Hepatitis B Vaccine and Immunoglobulin: Key Concepts.1 passage
• Hepatitis B and Delta Virus: Advances on Studies about Interactions between the Two Viruses and the Infected Hepatocyte.1 passage
• Hepatitis C Associated B-cell Non-Hodgkin Lymphoma: Clinical Features and the Role of Antiviral Therapy.1 passage
• Hepatitis C Screening: Barriers to Linkage to Care.1 passage
• Hepatitis C Virus Clearance by Direct-acting Antiviral Results in Rapid Resolution of Hepatocytic Injury as Indicated by Both Alanine Aminotransferase and Aspartate Aminotransferase Normalization.1 passage
• Hepatitis C Virus RNA Strands Detection in Peripheral Blood Mononuclear Cells Legitimizes Virus Eradication in Negative Serum PCR Naïve and Post-treatment Patients.1 passage
• Hepatitis C Virus and Hepatocellular Carcinoma: A Narrative Review.1 passage
• Hepatitis C Virus, Insulin Resistance, and Steatosis.1 passage
• Hepatitis C Virus: A Review of Treatment Guidelines, Cost-effectiveness, and Access to Therapy.1 passage
• Hepatitis E: A Literature Review.1 passage
• Hepatitis E: An Underdiagnosed, Emerging Infection in Nonendemic Regions.1 passage
• Hepatitis E: Still Waters Run Deep.1 passage
• Hepatobiliary Tumors: Update on Diagnosis and Management.1 passage
• Hepatocellular Carcinoma Related to Schistosoma mansoni Infection: Case Series and Literature Review.1 passage
• Hepatocellular Carcinoma and the Role of Liver Transplantation: A Review.1 passage
• Hepatocellular Carcinoma: Diagnosis, Treatment Algorithms, and Imaging Appearance after Transarterial Chemoembolization.1 passage
• Hepatocellular Carcinoma: Downstaging to Liver Transplantation as Curative Therapy.1 passage
• Hepatocellular Carcinoma: State of the Art Imaging and Recent Advances.1 passage
• Hepatopulmonary Syndrome and Liver Transplantation: A Recent Review of the Literature.1 passage
• Herb-induced Liver Injury in Asia and Current Role of RUCAM for Causality Assessment in 11,160 Published Cases.1 passage
• High Prevalent Hypovitaminosis D Is Associated with Dysregulation of Calcium-parathyroid Hormone-vitamin D Axis in Patients with Chronic Liver Diseases.1 passage
• Highlights for Dental Care as a Hepatitis C Risk Factor: A Review of Literature.1 passage
• Hispanic Patients with Primary Biliary Cholangitis Have Decreased Access to Care Compared to Non-Hispanics.1 passage
• Histological Outcome of Fuzheng Huayu plus Entecavir Combination Therapy in Chronic Hepatitis B Patients with Significant Liver Fibrosis.1 passage
• Histone Deacetylase Inhibitors Romidepsin and Vorinostat Promote Hepatitis B Virus Replication by Inducing Cell Cycle Arrest.1 passage
• Horizons on the Therapy of Biliary Tract Cancers: A State-of-the-art Review.1 passage
• Hypothyroidism and Nonalcoholic Fatty Liver Disease: Pathophysiological Associations and Therapeutic Implications.1 passage
• Hypoxic Hepatitis: A Review and Clinical Update.1 passage
• IL-6 Plays a Crucial Role in HBV Infection.1 passage
• Icaritin Attenuates Lipid Accumulation by Increasing Energy Expenditure and Autophagy Regulated by Phosphorylating AMPK.1 passage
• Identification of Nonalcoholic Fatty Liver Disease following Pancreatic Surgery in a Western Cohort Using a Novel Radiographic Technique.1 passage
• Immune Dysfunction in Cirrhosis.1 passage
• Impact of Different Embolic Agents for Transarterial Chemoembolization (TACE) Procedures on Systemic Vascular Endothelial Growth Factor (VEGF) Levels.1 passage
• Improved Outcomes Following Hepatocellular Carcinoma (HCC) Diagnosis in Patients Screened for HCC in a Large Academic Liver Center versus Patients Identified in the Community.1 passage
• Incidence, Mortality and Predictors of Acute Kidney Injury in Patients with Cirrhosis: A Systematic Review and Meta-analysis.1 passage
• Incidental Collision Tumor of Hepatocellular Carcinoma and Neuroendocrine Carcinoma.1 passage
• Inhibitor-Based Therapeutics for Treatment of Viral Hepatitis.1 passage
• Integration of Prealbumin into Child-Pugh Classification Improves Prognosis Predicting Accuracy in HCC Patients Considering Curative Surgery.1 passage
• Integrative Characterization of Immune-relevant Genes in Hepatocellular Carcinoma.1 passage
• Intensive Care Management of Acute Liver Failure: Considerations While Awaiting Liver Transplantation.1 passage
• Interaction of Hepatitis B Virus X Protein with the Pregnane X Receptor Enhances the Synergistic Effects of Aflatoxin B1 and Hepatitis B Virus on Promoting Hepatocarcinogenesis.1 passage
• Interferon-Free Treatments for Chronic Hepatitis C Genotype 1 Infection.1 passage
• Intrahepatic Cholangiocarcinoma and Thermal Ablation: Long-term Results of An Italian Retrospective Multicenter Study.1 passage
• Large Disparity between Prevalence and Treatment Rates for Hepatitis C in Western China.1 passage
• Limited Knowledge of Acetaminophen in Patients with Liver Disease.1 passage
• Liver Abscess in a Pediatric Patient with Ulcerative Colitis: A Case Presentation.1 passage
• Liver Dysfunction and Its Association with the Risk of Death in COVID-19 Patients: A Prospective Cohort Study.1 passage
• Liver Fibrosis Helps to Distinguish Autoimmune Hepatitis from DILI with Autoimmune Features: A Review of Twenty Cases.1 passage
• Liver Stiffness Measurement Can Reflect the Active Liver Necroinflammation in Population with Chronic Liver Disease: A Real-world Evidence Study.1 passage
• Liver Transplantation Beyond Milan Criteria.1 passage
• Liver Transplantation Services During the Time of COVID-19.1 passage
• Liver Transplantation for Hepatitis B Virus-related Hepatocellular Carcinoma in Hong Kong.1 passage
• Long-term Outcome of Autologous Hematopoietic Stem Cell Infusion in Cirrhosis: Waning Effect over Time.1 passage
• Loss of ARID1A Promotes Hepatocellular Carcinoma Progression via Up-regulation of MYC Transcription.1 passage
• Macrophage Phenotypes and Hepatitis B Virus Infection.1 passage
• Management and Treatment of Hepatocellular Carcinoma with Immunotherapy: A Review of Current and Future Options.1 passage
• Management of Hepatitis C Post-liver Transplantation: a Comprehensive Review.1 passage
• Management of Hepatorenal Syndrome: A Review.1 passage
• Massive Hemolysis Causing Renal Failure in Acute Hepatitis E Infection.1 passage
• Mechanisms and Prevention of Vertical Transmission in Chronic Viral Hepatitis.1 passage
• Mechanisms of Accelerated Liver Fibrosis Progression during HIV Infection.1 passage
• Metabolic Acidosis in Critically Ill Cirrhotic Patients with Acute Kidney Injury.1 passage
• Metabolic Disorders Combined with Noninvasive Tests to Screen Advanced Fibrosis in Nonalcoholic Fatty Liver Disease.1 passage
• Metabolic-associated Fatty Liver Disease as Assessed by the Fatty Liver Index Among Migrant and Non-migrant Ghanaian Populations.1 passage
• MicroRNAs as Important Players in Host-hepatitis B Virus Interactions.1 passage
• Microwave Ablation in Intermediate Hepatocellular Carcinoma in Cirrhosis: An Italian Multicenter Prospective Study.1 passage
• Minimal Hepatic Encephalopathy in Indians: Psychometric Hepatic Encephalopathy Score and Inhibitory Control Test for Diagnosis and Rifaximin or Lactulose for Its Reversal.1 passage
• Modulating the Intestinal Microbiota: Therapeutic Opportunities in Liver Disease.1 passage
• NAFLD Epidemiology, Emerging Pharmacotherapy, Liver Transplantation Implications and the Trends in the United States.1 passage
• New Drugs on the Block-Emerging Treatments for Nonalcoholic Steatohepatitis.1 passage
• New Evidence and Perspectives on the Management of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.1 passage
• Non-Hodgkin Lymphoma of the Liver: A US Population-based Analysis.1 passage
• Non-alcoholic Fatty Liver Disease in Lean Subjects: Characteristics and Implications.1 passage
• Non-alcoholic Fatty Liver Disease in South Asians: A Review of the Literature.1 passage
• Non-alcoholic Fatty Liver Disease: A Clinical Update.1 passage
• Non-alcoholic Fatty Liver Disease: A Review of Anti-diabetic Pharmacologic Therapies.1 passage
• Non-alcoholic Fatty Liver Disease: Growing Burden, Adverse Outcomes and Associations.1 passage
• Non-invasive1 passage
• Nonalcoholic Fatty Liver Disease (NAFLD) and Risk of Cardiac Arrhythmias: A New Aspect of the Liver-heart Axis.1 passage
• Nonalcoholic Fatty Liver Disease after Liver Transplant.1 passage
• Nonalcoholic Fatty Liver Disease: Dyslipidemia, Risk for Cardiovascular Complications, and Treatment Strategy.1 passage
• Nonalcoholic Fatty Liver Disease: Epidemiology, Liver Transplantation Trends and Outcomes, and Risk of Recurrent Disease in the Graft.1 passage
• Nonalcoholic Lipid Accumulation and Hepatocyte Malignant Transformation.1 passage
• Noncanonical NF-κB Signaling Pathway in Liver Diseases.1 passage
• Noninvasive Quantitative Detection Methods of Liver Fat Content in Nonalcoholic Fatty Liver Disease.1 passage
• Nontumoral Portal Vein Thrombosis: A Challenging Consequence of Liver Cirrhosis.1 passage
• Normothermic1 passage
• Novel Agents in the Management of Hepatic Encephalopathy: A Review.1 passage
• Novel Prognostic Models for Predicting the 180-day Outcome for Patients with Hepatitis-B Virus-related Acute-on-chronic Liver Failure.1 passage
• Novel Treatment of Hepatitis C Virus Infection for Patients with Renal Impairment.1 passage
• Obesity Paradox in Chronic Liver Diseases: Product of Bias or a Real Thing?1 passage
• Obstructive Jaundice Caused by Mucinous Cystic Tumor of Gallbladder: A Case Report and Literature Review.1 passage
• Occult HCV Infection (OCI) Diagnosis in Cirrhotic and Non-cirrhotic Naïve Patients by Intra-PBMC Nested Viral RNA PCR.1 passage
• Occult Hepatitis B Reactivation after Liver Transplant: The Role of a Novel Mutation in the Surface Antigen.1 passage
• Occult Hepatitis C Virus Infection: A Review.1 passage
• Oral Co-administration of Soy-derived Extracts with Alcohol or with Sugar-sweetened Beverages Exerts Liver and Sugar Protective Effects.1 passage
• Outcomes and Toxicology of Herbal Drugs in Alcoholic Hepatitis - A Single Center Experience from India.1 passage
• Overestimate of Fibrosis by FIBROSpect® II in African Americans Complicates the Management of their Chronic Hepatitis C.1 passage
• PD-1 Involvement in Peripheral Blood CD81 passage
• Passenger Lymphocyte Syndrome (PLS): A Single-center Retrospective Analysis of Minor ABO-incompatible Liver Transplants.1 passage
• Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease.1 passage
• Pathogenesis of Thrombocytopenia in Chronic HCV Infection: A Review.1 passage
• Pathophysiology and Prevention of Paracentesis-induced Circulatory Dysfunction: A Concise Review.1 passage
• Patients with Cirrhosis of Liver Operated for Non-transplant Surgery: A Retrospective Analysis.1 passage
• Patients with Gastric Antral Vascular Ectasia (GAVE) Are at a Higher Risk of Gastrointestinal Bleeding in the Absence of Cirrhosis.1 passage
• Performance of Non-invasive Blood Parameters for Ruling Out Significant Liver Fibrosis in Patients with Chronic Hepatitis B.1 passage
• Perspectives on Nonalcoholic Fatty Liver Disease: An Overview of Present and Future Therapies.1 passage
• Phenotypes and Chronic Organ Damage May Be Different among Siblings with Wilson's Disease.1 passage
• Portal Cavernoma Cholangiopathy in Children and the Management Dilemmas.1 passage
• Post Locoregional Therapy Treatment Imaging in Hepatocellular Carcinoma Patients: A Literature-based Review.1 passage
• Postoperative Risk of Hepatic Decompensation after Orthopedic Surgery in Patients with Cirrhosis.1 passage
• Potential Role and Clinical Value of PPP2CA in Hepatocellular Carcinoma.1 passage
• Practical Use of Transient Elastography in Screening for Nonalcoholic Steatohepatitis in a Japanese Population.1 passage
• Predicting Infiltrative Hepatocellular Carcinoma Patient Outcome Post-TACE: MR Bias Field Correction Effect on 3D-quantitative Image Analysis.1 passage
• Predictive Model of Ursodeoxycholic Acid Treatment Response in Primary Biliary Cholangitis.1 passage
• Predictive Value of Inflammation Biomarkers in Patients with Portal Vein Thrombosis.1 passage
• Predictors of Spontaneous Bacterial Peritonitis in Patients with Cirrhotic Ascites.1 passage
• Prevention and Treatment of Recurrent Hepatitis B after Liver Transplantation.1 passage
• Prevention of HBV Recurrence after Liver Transplant: A Review.1 passage
• Primary Sclerosing Cholangitis and Primary Biliary Cirrhosis Overlap Syndrome: A Review.1 passage
• Procalcitonin and Liver Disease: A Literature Review.1 passage
• Progress in the Clinical Features and Pathogenesis of Abnormal Liver Enzymes in Coronavirus Disease 2019.1 passage
• Pulmonary Manifestations among Patients with Primary Biliary Cirrhosis.1 passage
• Rapid Recovery in COVID-19 Patients with Chronic Hepatitis B Virus Infection Treated with Tenofovir Disoproxil Fumarate.1 passage
• Re-evaluating Transarterial Chemoembolization Failure/Refractoriness: A Survey by Chinese College of Interventionalists.1 passage
• Recent Advances Towards the Development of a Potent Antiviral Against the Hepatitis E Virus.1 passage
• Repurposing Pirfenidone for Nonalcoholic Steatohepatitis-related Cirrhosis: A Case Series.1 passage
• Review of Clinically Relevant Drug Interactions with Next Generation Hepatitis C Direct-acting Antiviral Agents.1 passage
• Ribavirin in Acute Hepatitis E Infection in Patients with Gynecological Cancer: A Case Series.1 passage
• Rising Rate of Liver Transplantation in the Baby Boomer Generation with Non-alcoholic Steatohepatitis in the United States.1 passage
• Risk Factors for the Development of Hepatocellular Carcinoma in Thailand.1 passage
• Risk of Cardiovascular Disease Due to Chronic Hepatitis C Infection: A Review.1 passage
• Risk of Cardiovascular Events in Patients with Primary Biliary Cholangitis - Systematic Review.1 passage
• Role of ALDH2 in Hepatic Disorders: Gene Polymorphism and Disease Pathogenesis.1 passage
• Role of Granulocyte Colony-stimulating Factor Therapy in Cirrhosis, 'Inside Any Deep Asking Is the Answering'.1 passage
• Role of Radiotherapy in the Treatment of Hepatocellular Carcinoma.1 passage
• Role of Ras-related Nuclear Protein/Polypyrimidine Tract Binding Protein in Facilitating the Replication of Hepatitis C Virus.1 passage
• Role of SREBPs in Liver Diseases: A Mini-review.1 passage
• Routine Laboratory Blood Tests May Diagnose Significant Fibrosis in Liver Transplant Recipients with Chronic Hepatitis C: A 10 Year Experience.1 passage
• Safety and Efficacy of Physical Thermal Ablation Combined Sorafenib for Hepatocellular Carcinoma: A Meta-analysis.1 passage
• Searching for Bacterial Biofilm in Recurrent Cholangitis in Primary Sclerosing Cholangitis: A Case Presentation and Introduction of an Unexplored Disease Mechanism.1 passage
• Serum N-terminal DDR1: A Novel Diagnostic Marker of Liver Fibrosis Severity.1 passage
• Serum Resistin Levels in Adult Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.1 passage
• Serum from Acute-on-chronic Liver Failure Patients May Affect Mesenchymal Stem Cells Transplantation by Impairing the Immunosuppressive Function of Cells.1 passage
• Severe Alcoholic Hepatitis: Atypical Presentation with Markedly Elevated Alkaline Phosphatase.1 passage
• Significant Histologic Changes Are Not Rare in Treatment-naive Hepatitis B Patients with Normal Alanine Aminotransferase Level: A Meta-analysis.1 passage
• Skeletal Muscle Dysfunction in the Development and Progression of Nonalcoholic Fatty Liver Disease.1 passage
• Sofosbuvir Use in the Setting of End-stage Renal Disease: A Single Center Experience.1 passage
• Sofosbuvir, a Significant Paradigm Change in HCV Treatment.1 passage
• Sofosbuvir-based Regimens with Task Shifting Is Cost-effective in Expanding Hepatitis C Treatment Access in the United States.1 passage
• Special Considerations in the Management of Autoimmune Hepatitis in COVID-19 Hotspots: A Review.1 passage
• Spectrum, Manifestations and Outcomes of Dengue Infection in Individuals with and without Liver Disease.1 passage
• Stratified Platelet-to-lymphocyte Ratio: A Novel Target for Prognostic Prediction of Hepatocellular Carcinoma after Curative Liver Resection.1 passage
• Successful Resection in a Case of Hepatocellular Carcinoma Masquerading as Hilar Cholangiocarcinoma: A Case Report.1 passage
• Superior Performance of Teaching and Transplant Hospitals in the Management of Hepatic Encephalopathy from 2007 to 2014.1 passage
• Supplementing Conventional Treatment with Pycnogenol® May Improve Hepatitis C Virus-Associated Type 2 Diabetes: A Mini Review.1 passage
• Sustained Responses in Chronic Hepatitis B Patients with Nucleos(t)ide Analogue Drug-resistance after Peg-interferon Alfa-2a Add-on Treatment: A Long-term Cohort Study.1 passage
• Systematic Review and Meta-analysis of Circulating Fetuin-A Levels in Nonalcoholic Fatty Liver Disease.1 passage
• Systematic Training of Liver Imaging Reporting and Data System Magnetic Resonance Imaging v2018 can Improve the Diagnosis of Hepatocellular Carcinoma for Different Radiologists.1 passage
• TIPS Is Not Associated with a Higher Risk of Developing HCC in Cirrhotic Patients: A Systematic Review and Meta-analysis.1 passage
• TM6SF2 E167K Variant, a Novel Genetic Susceptibility Variant, Contributing to Nonalcoholic Fatty Liver Disease.1 passage
• Tenofovir Alafenamide Fumarate, Tenofovir Disoproxil Fumarate and Entecavir: Which is the Most Effective Drug for Chronic Hepatitis B? A Systematic Review and Meta-analysis.1 passage
• The Association between Meteorological Factors and the Prevalence of Acute-on-chronic Liver Failure: A Population-based Study, 2007-2016.1 passage
• The Direct Contribution of Astrocytes and Microglia to the Pathogenesis of Hepatic Encephalopathy.1 passage
• The Evolving Nature of Hepatic Abscess: A Review.1 passage
• The Genetics of Clinical Liver Diseases: Insight into the1 passage
• The Number of Positive Tumor Marker Status Is Beneficial for the Selection of Therapeutic Modalities in Patients with Hepatocellular Carcinoma.1 passage
• The Reliability of Fibro-test in Staging Orthotopic Liver Transplant Recipients with Recurrent Hepatitis C.1 passage
• The Role of Direct-acting Antivirals in the Treatment of Children with Chronic Hepatitis C.1 passage
• The Role of Immune Cells in Chronic HBV Infection.1 passage
• Therapeutic Roles of Bile Acid Signaling in Chronic Liver Diseases.1 passage
• Thrombotic Venous Diseases of the Liver.1 passage
• Timing of Hepatitis C Virus Treatment in Liver Transplant Candidates in the Era of Direct-acting Antiviral Agents.1 passage
• Transaminitis in a Three-year-old Boy with Duchenne Muscular Dystrophy.1 passage
• Transplantation of HCV Viremic Livers into HCV Viremic Recipients Followed by Direct-acting Antiviral Therapy.1 passage
• Treatment of Hepatitis C in Patients Undergoing Immunosuppressive Drug Therapy.1 passage
• Treatment of Nonalcoholic Fatty Liver Disease: The Role of Medical, Surgical, and Endoscopic Weight Loss.1 passage
• UMSCs Attenuate LPS/D-GalN-induced Acute Liver Failure in Mice by Down-regulating the MyD88/NF-κB Pathway.1 passage
• Underutilization of Living Donor Liver Transplantation in the United States: Bias against MELD 20 and Higher.1 passage
• Update on Autoimmune Hepatitis.1 passage
• Update on Liver Failure Following Hepatic Resection: Strategies for Prediction and Avoidance of Post-operative Liver Insufficiency.1 passage
• Update on Management of Portal Vein Thrombosis and the Role of Novel Anticoagulants.1 passage
• Upgrade Combination Response Is Limited by Prolonged Nucelos(t)ide Analogue Therapy in HBeAg-positive Chronic Hepatitis B: A Real-life Study.1 passage
• Ursodeoxycholic Acid in Treatment of Non-cholestatic Liver Diseases: A Systematic Review.1 passage
• Use of Ribavirin for Hepatitis C Treatment in the Modern Direct-acting Antiviral Era.1 passage
• Validation of the Nanjing Criteria for Diagnosing Pyrrolizidine Alkaloids-induced Hepatic Sinusoidal Obstruction Syndrome.1 passage
• Vascular Diseases of the Spleen: A Review.1 passage
• Vitamin D Deficiency and Its Relationship with Child-Pugh Class in Patients with Chronic Liver Disease.1 passage
• Vitamin D Is Associated with Severity and Mortality of Non-alcoholic Fatty Liver Disease: A US Population-based Study.1 passage
• miR-29a Promotes Lipid Droplet and Triglyceride Formation in HCV Infection by Inducing Expression of SREBP-1c and CAV1.1 passage
• miR-34a: Multiple Opposing Targets and One Destiny in Hepatocellular Carcinoma.1 passage